TipRanks
Go Ultimate55% OFF

Compare Lionheart Holdings Class A (CUB) vs. Competitors

6 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CUBLionheart Holdings Class A$10.95$286.22M199.093.01%―Unlock the CUB analyst price target with TipRanks PremiumCUBUnlock the CUB top-analyst price target with TipRanks Premium
TVAIThayer Ventures Acquisition Corporation II Class A$10.46$284.47M40.423.82%―Unlock the TVAI analyst price target with TipRanks PremiumCUB vs TVAIUnlock the TVAI top-analyst price target with TipRanks Premium
AXINAxiom Intelligence Acquisition Corporation 1 Class A$10.40$283.85M34.443.38%―Unlock the AXIN analyst price target with TipRanks PremiumCUB vs AXINUnlock the AXIN top-analyst price target with TipRanks Premium
PAIIPyrophyte Acquisition Corp. II Class A$10.35$282.21M46.022.73%―Unlock the PAII analyst price target with TipRanks PremiumCUB vs PAIIUnlock the PAII top-analyst price target with TipRanks Premium
XCBEX3 Acquisition Corp.$10.02$282.37M82.611.21%―Unlock the XCBE analyst price target with TipRanks PremiumCUB vs XCBEUnlock the XCBE top-analyst price target with TipRanks Premium
KEYYKeystone Acquisition$9.92$285.20M―0.00%―Unlock the KEYY analyst price target with TipRanks PremiumCUB vs KEYYUnlock the KEYY top-analyst price target with TipRanks Premium

Performance Comparison

-2%-1%0%1%2%3%4%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CUBLionheart Holdings Class A10.950.323.01%
TVAIThayer Ventures Acquisition Corporation II Class A10.460.383.77%
AXINAxiom Intelligence Acquisition Corporation 1 Class A10.400.343.38%
PAIIPyrophyte Acquisition Corp. II Class A10.350.292.83%
XCBEX3 Acquisition Corp.10.020.121.21%
KEYYKeystone Acquisition9.920.000.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts